tiprankstipranks
Incannex Healthcare Reports Q3 Loss, Secures New Funding
PremiumCompany AnnouncementsIncannex Healthcare Reports Q3 Loss, Secures New Funding
4M ago
Incannex files $150M mixed securities shelf
Premium
The Fly
Incannex files $150M mixed securities shelf
4M ago
Incannex files to sell 61.39M shares of common stock for holders
Premium
The Fly
Incannex files to sell 61.39M shares of common stock for holders
4M ago
Incannex completes participate dosing in IHL-42X BA/BE trial
PremiumThe FlyIncannex completes participate dosing in IHL-42X BA/BE trial
7M ago
Incannex announces patient dosing commenced in Phase 2/3 trial of IHL-42X
Premium
The Fly
Incannex announces patient dosing commenced in Phase 2/3 trial of IHL-42X
9M ago
Incannex completes pre-IND meeting with FDA for CannQuit-O
Premium
The Fly
Incannex completes pre-IND meeting with FDA for CannQuit-O
10M ago
Incannex: Dosing commenced in HCQ-CBD combo IHL-675A in patients with RA
PremiumThe FlyIncannex: Dosing commenced in HCQ-CBD combo IHL-675A in patients with RA
1y ago
Incannex completes dosing, therapy in Phase 2 PsiGAD trial
Premium
The Fly
Incannex completes dosing, therapy in Phase 2 PsiGAD trial
1y ago
Incannex receives IRB approval for RePOSA Phase 2/3 trial protocol
Premium
The Fly
Incannex receives IRB approval for RePOSA Phase 2/3 trial protocol
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100